Astrocytes are active players in cerebral innate immunity

Trends in Immunology

Volumn 28, Issue 3, 2007, Pages 138-145

  Farina, Cinthia ^a   Aloisi, Francesca ^b   Meinl, Edgar ^c,d  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF MUNICH   (Germany)

^d MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; MANNOSE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEOTIDE; PROTEIN KINASE R; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ASTROCYTE; BONE MARROW CELL; CELL ACTIVATION; CELL SPECIFICITY; CELL TYPE; CENTRAL NERVOUS SYSTEM; COMPLEMENT SYSTEM; GENE EXPRESSION; GENE TARGETING; GLIA CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; NEUROPROTECTION; NONHUMAN; OLIGOMERIZATION; PROTEIN DOMAIN; REVIEW; SIGNAL TRANSDUCTION; TISSUE REPAIR;

ANIMALS; ASTROCYTES; BRAIN; EIF-2 KINASE; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; RECEPTORS, CELL SURFACE; RECEPTORS, SCAVENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 33847099936     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2007.01.005     Document Type: Review

References (99)

1. Galea I., et al. What is immune privilege (not)?. Trends Immunol. 28 (2007) 12-18
2. Nguyen M.D., et al. Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nat. Rev. Neurosci. 3 (2002) 216-227
3. Aloisi F. Immune function of microglia. Glia 36 (2001) 165-179
4. Dong Y., and Benveniste E.N. Immune function of astrocytes. Glia 36 (2001) 180-190
5. Bechmann I., et al. What is the blood-brain barrier (not)?. Trends Immunol. 28 (2007) 5-11
6. Song J.H., et al. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. J. Neurosci. 26 (2006) 3299-3308
7. Akira S., et al. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
8. Emonts M., et al. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect. Dis. 3 (2003) 565-577
9. Echchannaoui H., et al. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J. Infect. Dis. 186 (2002) 798-806
10. Koedel U., et al. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immunol. 170 (2003) 438-444
11. Kurt-Jones E.A., et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 1315-1320
12. Laflamme N., and Rivest S. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating Gram-negative bacterial cell wall components. FASEB J. 15 (2001) 155-163
13. Laflamme N., et al. Cooperation between Toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from Gram-negative and Gram-positive bacteria. Eur. J. Immunol. 33 (2003) 1127-1138
14. Laflamme N., et al. Circulating cell wall components derived from Gram-negative, not Gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J. Neurochem. 79 (2001) 648-657
15. Chakravarty S., and Herkenham M. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci. 25 (2005) 1788-1796
16. Park C., et al. TLR3-mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: differential signaling mechanisms of TLR3-induced IP-10 and IL-8 gene expression. Glia 53 (2006) 248-256
17. Farina C., et al. Preferential expression and function of Toll-like receptor 3 in human astrocytes. J. Neuroimmunol. 159 (2005) 12-19
18. Jack C.S., et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 175 (2005) 4320-4330
19. Bsibsi M., et al. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 53 (2006) 688-695
20. Carpentier P.A., et al. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49 (2005) 360-374
21. Scumpia P.O., et al. Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes. Glia 52 (2005) 153-162
22. Bsibsi M., et al. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61 (2002) 1013-1021
23. Bowman C.C., et al. Cultured astrocytes express Toll-like receptors for bacterial products. Glia 43 (2003) 281-291
24. Olson J.K., and Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173 (2004) 3916-3924
25. Town T., et al. Microglia recognize double-stranded RNA via TLR3. J. Immunol. 176 (2006) 3804-3812
26. Brahmachari S., et al. Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J. Neurosci. 26 (2006) 4930-4939
27. Zhao Y., et al. The TLR3 ligand polyI:C downregulates connexin 43 expression and function in astrocytes by a mechanism involving the NF-κB and PI3 kinase pathways. Glia 54 (2006) 775-785
28. So E.Y., et al. Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3. Glia 53 (2006) 858-867
29. Rivieccio M.A., et al. TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J. Immunol. 177 (2006) 4735-4741
30. Kariko K., et al. mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 279 (2004) 12542-12550
31. Edelmann K.H., et al. Does Toll-like receptor 3 play a biological role in virus infections?. Virology 322 (2004) 231-238
32. Elco C.P., et al. Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-κB, and interferon but not Toll-like receptor 3. J. Virol. 79 (2005) 3920-3929
33. Saunders L.R., and Barber G.N. The dsRNA binding protein family: critical roles, diverse cellular functions. FASEB J. 17 (2003) 961-983
34. Okahira S., et al. Interferon-β induction through Toll-like receptor 3 depends on double-stranded RNA structure. DNA Cell Biol. 24 (2005) 614-623
35. Ong C.L., et al. Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response. J. Virol. 79 (2005) 12763-12772
36. Sterka Jr. D., et al. Functional expression of NOD2, a novel pattern recognition receptor for bacterial motifs, in primary murine astrocytes. Glia 53 (2006) 322-330
37. Burudi E.M., et al. Identification and functional characterization of the mannose receptor in astrocytes. Glia 25 (1999) 44-55
38. Liu Y., et al. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J. Virol. 78 (2004) 4120-4133
39. Lopez-Herrera A., et al. HIV-1 interaction with human mannose receptor (hMR) induces production of matrix metalloproteinase 2 (MMP-2) through hMR-mediated intracellular signaling in astrocytes. Biochim. Biophys. Acta 1741 (2005) 55-64
40. Gasque P., et al. Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 49 (2000) 171-186
41. Hauwel M., et al. Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, 'protective' glial stem cells and stromal ependymal cells. Brain Res. Brain Res. Rev. 48 (2005) 220-233
42. Ohlsson M., et al. Complement activation following optic nerve crush in the adult rat. J. Neurotrauma 20 (2003) 895-904
43. Cattaneo R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J. Virol. 78 (2004) 4385-4388
44. Gill D.B., and Atkinson J.P. CD46 in Neisseria pathogenesis. Trends Mol. Med. 10 (2004) 459-465
45. Ochsenbein A.F., et al. Protective T cell-independent antiviral antibody responses are dependent on complement. J. Exp. Med. 190 (1999) 1165-1174
46. Mehlhop E., et al. Complement activation is required for induction of a protective antibody response against West Nile virus infection. J. Virol. 79 (2005) 7466-7477
47. Mehlhop E., and Diamond M.S. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 203 (2006) 1371-1381
48. Husemann J., et al. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 40 (2002) 195-205
49. Murphy J.E., et al. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 182 (2005) 1-15
50. Mukhopadhyay S., et al. MARCO, an innate activation marker of macrophages, is a class A scavenger receptor for Neisseria meningitides. Eur. J. Immunol. 36 (2006) 940-949
51. Alarcon R., et al. Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound β-amyloid. J. Biol. Chem. 280 (2005) 30406-30415
52. Verdier Y., et al. Amyloid β-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J. Pept. Sci. 10 (2004) 229-248
53. Nakamura K., et al. Possible role of scavenger receptor SRCL in the clearance of amyloid-β in Alzheimer's disease. J. Neurosci. Res. 84 (2006) 874-890
54. Wyss-Coray T., et al. Adult mouse astrocytes degrade amyloid-β in vitro and in situ. Nat. Med. 9 (2003) 453-457
55. Krumbholz M., et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 201 (2005) 195-200
56. Tschen S.I., et al. CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. Eur. J. Immunol. 36 (2006) 603-612
57. Brambilla R., et al. Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 202 (2005) 145-156
58. van Loo G., et al. Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat. Immunol. 7 (2006) 954-961
59. Bush T.G., et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23 (1999) 297-308
60. Faulkner J.R., et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24 (2004) 2143-2155
61. Herx L.M., et al. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1β is required for the production of ciliary neurotrophic factor. J. Immunol. 165 (2000) 2232-2239
62. Herx L.M., and Yong V.W. Interleukin-1β is required for the early evolution of reactive astrogliosis following CNS lesion. J. Neuropathol. Exp. Neurol. 60 (2001) 961-971
63. Mason J.L., et al. Interleukin-1β promotes repair of the CNS. J. Neurosci. 21 (2001) 7046-7052
64. Penkowa M., et al. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia 25 (1999) 343-357
65. Swartz K.R., et al. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res. 896 (2001) 86-95
66. Liberto C.M., et al. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89 (2004) 1092-1100
67. Tran P.B., and Miller R.J. Chemokine receptors: signposts to brain development and disease. Nat. Rev. Neurosci. 4 (2003) 444-455
68. Imitola J., et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 18117-18122
69. Pluchino S., et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436 (2005) 266-271
70. Belmadani A., et al. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J. Neurosci. 26 (2006) 3182-3191
71. Babcock A.A., et al. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 23 (2003) 7922-7930
72. Ambrosini E., and Aloisi F. Chemokines and glial cells: a complex network in the central nervous system. Neurochem. Res. 29 (2004) 1017-1038
73. Ambrosini E., et al. Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 64 (2005) 706-715
74. Krumbholz M., et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 129 (2006) 200-211
75. Omari K.M., et al. Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 53 (2006) 24-31
76. Cardona A.E., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9 (2006) 917-924
77. Wang T., et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10 (2004) 1366-1373
78. Prinz M., et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 116 (2006) 456-464
79. Tanga F.Y., et al. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5856-5861
80. Kariko K., et al. Inhibition of Toll-like receptor and cytokine signaling - a unifying theme in ischemic tolerance. J. Cereb. Blood Flow Metab. 24 (2004) 1288-1304
81. Ding Q., and Keller J.N. Evaluation of rage isoforms, ligands, and signaling in the brain. Biochim. Biophys. Acta 1746 (2005) 18-27
82. Eto M., et al. The role of CD36 in peripheral nerve remyelination after crush injury. Eur. J. Neurosci. 17 (2003) 2659-2666
83. Cho S., et al. The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia. J. Neurosci. 25 (2005) 2504-2512
84. McGeer P.L., and McGeer E.G. The possible role of complement activation in Alzheimer disease. Trends Mol. Med. 8 (2002) 519-523
85. Bonifati D.M., and Kishore U. Role of complement in neurodegeneration and neuroinflammation. Mol. Immunol. 44 (2007) 999-1010
86. Storch M.K., et al. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 43 (1998) 465-471
87. Boos L., et al. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis. J. Immunol. 173 (2004) 4708-4714
88. Whitney K.D., et al. Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis. Neurology 53 (1999) 699-708
89. Speth C., et al. Neuroinvasion by pathogens: a key role of the complement system. Mol. Immunol. 38 (2002) 669-679
90. de Jonge R.R., et al. Expression of complement components in the peripheral nervous system. Hum. Mol. Genet. 13 (2004) 295-302
91. Rahpeymai Y., et al. Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J. 25 (2006) 1364-1374
92. Nadeau S., and Rivest S. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor κB activity in the brain during endotoxemia. J. Neurosci. 20 (2000) 3456-3468
93. Lee J.H., et al. Double-stranded RNA-activated protein kinase is required for the LPS-induced activation of STAT1 inflammatory signaling in rat brain glial cells. Glia 50 (2005) 66-79
94. Husemann J., and Silverstein S.C. Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain. Am. J. Pathol. 158 (2001) 825-832
95. Sasaki N., et al. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res. 888 (2001) 256-262
96. Dorf M.E., et al. Astrocytes express functional chemokine receptors. J. Neuroimmunol. 111 (2000) 109-121
97. John G.R., et al. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 8 (2002) 1115-1121
98. John G.R., et al. IL-1-regulated responses in astrocytes: relevance to injury and recovery. Glia 49 (2005) 161-176
99. Rivieccio M.A., et al. The cytokine IL-1β activates IFN response factor 3 in human fetal astrocytes in culture. J. Immunol. 174 (2005) 3719-3726